CrossrefInfokarte
A Real‑World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
American Journal of Cardiovascular Drugs · 2024-11 · 24 (6) · 791-799
DOI: 10.1007/s40256-024-00672-2 ↗Abstract
Kein Abstract verfügbar.
EUVIMED